Vertex Pharmaceuticals Inc
BMV:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
Samsung Electronics Co Ltd
F:SSU
|
KR |
|
L
|
Lumentum Holdings Inc
DUS:LU2
|
US |
|
Perusahaan Gas Negara Tbk PT
IDX:PGAS
|
ID |
|
I
|
Intuit Inc
XMUN:ITU
|
US |
|
Waters Corp
NYSE:WAT
|
US |
|
RWS Holdings PLC
OTC:RWSPF
|
UK |
|
K
|
Karman Holdings Inc
NYSE:KRMN
|
US |
|
N
|
Newmont Corporation
F:NMM
|
US |
|
S
|
Schroders PLC
F:PYXA
|
UK |
|
Anterix Inc
NASDAQ:ATEX
|
US |
|
A
|
Agricultural Bank of China Ltd
DUS:EK7
|
CN |
|
L
|
Lockheed Martin Corp
DUS:LOM
|
US |
|
O
|
Orange County Bancorp Inc
NASDAQ:OBT
|
US |
|
R
|
RWE AG
SWB:RWE
|
DE |
|
E
|
Eiffage SA
F:EF3
|
FR |
|
Eiffage SA
OTC:EFGSF
|
FR |
|
Anterix Inc
F:2X6
|
US |
|
R
|
Rio Tinto Ltd
XHAM:CRA1
|
AU |
|
G
|
General Electric Co
XMUN:GCP
|
US |
|
Dassault Systemes SE
OTC:DASTF
|
FR |
|
Agricultural Bank of China Ltd
F:EK7
|
CN |
|
B
|
Brunello Cucinelli SpA
F:8BU
|
IT |
|
RWE AG
MIL:1RWE
|
DE |
Wall St Price Targets
VRTX Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VRTX is 9 789.17 MXN with a low forecast of 6 121.6 MXN and a high forecast of 11 855.3 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
9 789.17
MXN
According to Wall Street analysts, the average 1-year price target for VRTX is 9 789.17 MXN with a low forecast of 6 121.6 MXN and a high forecast of 11 855.3 MXN.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 8 years is 14%.
